Short interest in Amicus Therapeutics Inc (NASDAQ:FOLD) decreased during the last reporting period, falling from 21.94M to 19.90M. This put 6.76% of the company's publicly available shares short.

Short interest for Amicus Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Amicus Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 2.78M shares traded per day, it would take 7.16 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.